Related Experiment Videos
Multiple myeloma complicated by autoimmune hemolytic anemia
Hideho Wada1, Kenichiro Yata, Makoto Mikami
1Division of Hematology, Department of Medicine, Kawasaki Medical School, Kurashiki, Okayama.
Internal Medicine (Tokyo, Japan)
|September 1, 2004
Summary
This study investigates a patient with multiple myeloma and autoimmune hemolytic anemia. Chemotherapy improved anemia, but the direct link between the myeloma protein and red blood cell destruction remained uncertain.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Multiple myeloma is a plasma cell malignancy.
- Autoimmune hemolytic anemia (AIHA) involves red blood cell destruction by the immune system.
- Hypergammaglobulinemia can be associated with both conditions.
Observation:
- A 57-year-old male presented with severe anemia and hypergammaglobulinemia.
- Diagnosis of multiple myeloma and AIHA was established.
- Chemotherapy led to decreased M-protein and anemia resolution, with a normalized direct Coombs test.
Findings:
- The patient's red blood cells were coated with immunoglobulin G kappa chain, matching the myeloma M-protein.
- Monoclonal immunoglobulin G from bone marrow cell cultures did not bind to red blood cells.
- The precise mechanism linking myeloma M-protein to hemolysis was not definitively established.
Implications:
- Understanding the complex interplay between plasma cell dyscrasias and autoimmune phenomena is crucial.
- Further research is needed to elucidate the specific pathogenic mechanisms in such cases.
- This case highlights the diagnostic challenges in co-existing multiple myeloma and AIHA.